Creation of Substitution Labile Pyrazolylborate Metal Complexes
取代不稳定的吡唑基硼酸盐金属配合物的制备
基本信息
- 批准号:09640675
- 负责人:
- 金额:$ 0.96万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
(1) Bis[dihydrobis(3,5-bis(trifluoromethyl)pyrazolyl)borate]cobalt was prepared and the structure was determined by X ray crystallographic analysis. The cobalt center is coordinated to four pyrazolyl groups in a square planner manner and to two B-H groups at the axial positions forming totally a distorted octahedral configuration. This is in marked contrast to those of known non-substituted and 3, 5-dimethyl substituted pyrazolylborate derivatives which appear inn a tetrahedral configuration Similar nickel complex having a B-H-M agostic interaction was prepared.(2) Bis(triphenylphosphine)[dihydrobis(3,5-R_2-pyrazolyl)borate]ruthenium hydrides (R=H, Me, CF_3) were prepared and the structures containing a B-H-Ru agostic interaction were determined by X ray crystallography. Based on the reactivity with CO, strength of the agostic interaction was estimated to decrease in the order, Me> H * CF_3.(3) Bis(triphenylphosphine)[dihydrobis(3, 5-R_2-pyrazolyl)borate]rhodium complexes (R=H, Me, CF_3) were prepared and the structures were determined by X ray crystallographic analysis. The rhodium centers are coordinated in a square planner manner to the four pyrazolyl groups. No B-H-Rh agostic interactions were observed in these complexes.(4) eta^3-Allyl and indenyl[hydrotris(3,5-R_2-pyrazolyl)borate]palladium complexes (R=H, Me, CF_3) were prepared and the structures were determined by X ray crystallographic analysis. Their fluxional behavior in solution were studied by NMR spectroscopy.
(1)制备了双[二氢双(3,5-二(三氟甲基)吡唑基)硼酸盐]钴,并通过X射线晶体学分析确定了其结构。钴中心与四个吡唑基以正方形规划方式配位,在轴向位置与两个B-H基配位,形成完全扭曲的八面体构型。这与已知的非取代和3,5 -二甲基取代吡唑硼酸酯衍生物形成鲜明对比,它们以四面体结构出现,类似的镍配合物具有B-H-M相互作用。(2)制备了双(三苯基膦)[二氢双(3,5- r_2 -吡唑基)硼酸盐]钌氢化物(R=H, Me, CF_3),并用X射线晶体学对其结构进行了表征。根据与CO的反应性,估算出有机相互作用的强度按Me> H * CF_3的顺序递减。(3)制备了双(三苯基膦)[二氢双(3,5 - r_2 -吡唑基)硼酸盐]铑配合物(R=H, Me, CF_3),并通过X射线晶体学分析对其结构进行了表征。铑的中心以方形规划的方式与四个吡唑基协调。在这些配合物中没有观察到B-H-Rh的相互作用。(4)制备了eta^3-烯丙基和茚基[氢化(3,5- r_2 -吡唑基)硼酸盐]钯配合物(R=H, Me, CF_3),并通过X射线晶体学分析对其结构进行了表征。用核磁共振波谱法研究了它们在溶液中的流动行为。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YAMAZAKI Hiroshi其他文献
YAMAZAKI Hiroshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YAMAZAKI Hiroshi', 18)}}的其他基金
Relevance to bioactivation and toxicity of thalidomide, pomalidomide, and lenalidomide by human cytochrome P450 3A enzymes in cultured placental cells and humanized-liver mice
培养胎盘细胞和人源化肝小鼠中人细胞色素 P450 3A 酶与沙利度胺、泊马度胺和来那度胺生物活性和毒性的相关性
- 批准号:
17K08425 - 财政年份:2017
- 资助金额:
$ 0.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanisms of resistance to molecularly targeted drugs for oral squamous cell carcinoma and investigation of countermeasures
口腔鳞癌分子靶向药物耐药机制及对策研究
- 批准号:
16K11732 - 财政年份:2016
- 资助金额:
$ 0.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of Effective Markers for Resistance of Oral Squamous Cell Carcinoma to Molecular-targeting Drugs
口腔鳞状细胞癌分子靶向药物耐药性有效标志物的开发
- 批准号:
25463120 - 财政年份:2013
- 资助金额:
$ 0.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Thalidomide increases cytochrome P450 activity and drug metabolism in liver through direct activation of nuclear receptor CAR and PXR
沙利度胺通过直接激活核受体 CAR 和 PXR 增加肝脏细胞色素 P450 活性和药物代谢
- 批准号:
23590200 - 财政年份:2011
- 资助金额:
$ 0.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
evaluationofeffectivenessoftheobjectiveexaminationforautism indeafchildren
聋儿自闭症客观检查效果评价
- 批准号:
22791642 - 财政年份:2010
- 资助金额:
$ 0.96万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Role of cancer stem cells related molecules in oral squamous cell carcinoma
肿瘤干细胞相关分子在口腔鳞癌中的作用
- 批准号:
22592246 - 财政年份:2010
- 资助金额:
$ 0.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanism of chemical-induced toxicity in fetal livers
化学品致胎儿肝脏毒性的分子机制
- 批准号:
17390034 - 财政年份:2005
- 资助金额:
$ 0.96万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular Mechanisms of Toxic Expression Induced by Endocrine Disruptors via AHR
内分泌干扰物通过 AHR 诱导毒性表达的分子机制
- 批准号:
15390040 - 财政年份:2003
- 资助金额:
$ 0.96万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Study on the separation of rac and meso isomers and the reactivity of group 4 bridged metallocene complexes
外消旋和内消旋异构体的分离及第4族桥联茂金属配合物的反应性研究
- 批准号:
11640544 - 财政年份:1999
- 资助金额:
$ 0.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
PREDICTION OF DRUG DISPOSITION BY HUMAN DRUG METABOLIZING ENZYMES
通过人体药物代谢酶预测药物分布
- 批准号:
11557191 - 财政年份:1999
- 资助金额:
$ 0.96万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
相似海外基金
New Catalysts for Cis-Selective Metathesis: Agostic Interaction and Meso-N-Heterocyclic Carbenes
顺式选择性复分解的新催化剂:不规则相互作用和内消旋-N-杂环卡宾
- 批准号:
0848560 - 财政年份:2009
- 资助金额:
$ 0.96万 - 项目类别:
Continuing Grant














{{item.name}}会员




